(S)-2-(3-octyl-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide hydrochloride

ID: ALA3627777

Chembl Id: CHEMBL3627777

PubChem CID: 122192898

Max Phase: Preclinical

Molecular Formula: C15H28ClN5O

Molecular Weight: 293.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCc1noc([C@@H]2CCCN2C(=N)N)n1.Cl

Standard InChI:  InChI=1S/C15H27N5O.ClH/c1-2-3-4-5-6-7-10-13-18-14(21-19-13)12-9-8-11-20(12)15(16)17;/h12H,2-11H2,1H3,(H3,16,17);1H/t12-;/m0./s1

Standard InChI Key:  HYBXJKXKSUCKOQ-YDALLXLXSA-N

Associated Targets(Human)

SPHK1 Tchem Sphingosine kinase 1 (1990 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sphk2 Sphingosine kinase 2 (214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 293.42Molecular Weight (Monoisotopic): 293.2216AlogP: 3.00#Rotatable Bonds: 8
Polar Surface Area: 92.03Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 11.22CX LogP: 3.70CX LogD: 1.23
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.44Np Likeness Score: -0.90

References

1. Congdon MD, Childress ES, Patwardhan NN, Gumkowski J, Morris EA, Kharel Y, Lynch KR, Santos WL..  (2015)  Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.,  25  (21): [PMID:25862200] [10.1016/j.bmcl.2015.03.041]

Source